Eltor Pharmaceuticals Private Limited
About Eltor Pharmaceuticals Private Limited
Data last updated:
Eltor Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 14 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2016PTC288475. Its GSTIN is 09AAECE4744Q1Z0 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Brijesh Kumar Gautam and Atul Kumar Rai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R No 7 Ramsukh Singh Rambodh Chawl Adarsh Lane Jawahar Nagar Chawl No. 3 Khar (East), Mumbai, Maharashtra, India – 400051.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.07 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.16 Lakh (net margin 2.2%) and EBITDA of ₹1.79 Lakh (EBITDA margin 3.4%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹9.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressR No 7 Ramsukh Singh Rambodh Chawl Adarsh Lane Jawahar Nagar Chawl No. 3 Khar (East), Mumbai, Maharashtra, India – 400051
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Eltor Pharmaceuticals Private Limited
The main business activity of Eltor Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Eltor Pharmaceuticals Private Limited
Eltor Pharmaceuticals Private Limited is audited by A R S S & Co. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A R S S & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Eltor Pharmaceuticals Private Limited
Eltor Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brijesh Kumar Gautam | Director | 02 Jul 2025 | 1 Years 3 Months | Current |
| Atul Kumar Rai | Director | 02 Jul 2025 | 1 Years 3 Months | Current |
Financials of Eltor Pharmaceuticals Private Limited FY 2025 filings available
Eltor Pharmaceuticals Private Limited reported revenue of ₹53.07 Lakh (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Eltor Pharmaceuticals Private Limited
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Eltor Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.79 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.16 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Eltor Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Eltor Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Eltor Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Eltor Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2022 | Others | ₹9.5 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Eltor Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Eltor Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Eltor Pharmaceuticals Private Limited
Eltor Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECE4744Q1Z0 | Uttar Pradesh | Active | 08 May 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Eltor Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eltor Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eltor Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eltor Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Eltor Pharmaceuticals Private Limited
Frequently Asked Questions about Eltor Pharmaceuticals Private Limited
Eltor Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in human health activities, within the healthcare industry. It was incorporated on 14 December 2016 (10+ years old) and is registered under CIN U85100MH2016PTC288475.
Eltor Pharmaceuticals reported revenue of ₹53.07 Lakh for FY 2025 (up 9% YoY).
Eltor Pharmaceuticals has 2 current directors:
- Brijesh Kumar Gautam - Director
- Atul Kumar Rai - Director
Eltor Pharmaceuticals reported a net profit of ₹1.16 Lakh (net margin 2.2%) and EBITDA of ₹1.79 Lakh (EBITDA margin 3.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Eltor Pharmaceuticals is -1% over three years and -1% over five years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Eltor Pharmaceuticals is 09AAECE4744Q1Z0, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Eltor Pharmaceuticals is U85100MH2016PTC288475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eltor Pharmaceuticals was incorporated on 14 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The registered office of Eltor Pharmaceuticals is at R No 7 Ramsukh Singh Rambodh Chawl Adarsh Lane Jawahar Nagar Chawl No. 3 Khar East, Mumbai, Maharashtra, India – 400051.